SC 13G/A: Apollomics Inc.

AI Summary

SC 13G/A filing by Apollomics Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.0001 — er) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• ea0207102-13ga1maxpro_apollo.htm (SC 13G/A) — 34KB
• 0001213900-24-047989.txt ( ) — 36KB

Ownership

Item 4. Ownership: Information with respect to the beneficial ownership of securities of the Reporting Person , is incorporated by reference to items (5) - (9) and (11) of the cover page for the Reporting Person . As reported in the cover page to this report, the ownership information with respect to the Reporting Person is as follows: (a) Amount Beneficially Owned: See line 9 of page 2. (b) Percent of Class: See line 11 of page 2. (c) Number of Shares as to which such person has: (i) Sole power to vote or to direct the vote: See line 5 of page 2. (ii) Shared power to vote or to direct the vote: See line 6 of page 2. (iii) Sole power to dispose or to direct the disposition of: See line 7 of page 2. (iv) Shared power to dispose or to direct the disposition of: See line 8 of page 2. As of the date of this filing, the Reporting Person may be deemed to beneficially own 10,577,029 Class A ordinary Class A Ordinary Shares, consisting of (i) 10,194,634 Class A Ordinary Shares and (ii) 382,395 Class A Ordinary Shares issuable upon exercise of warrants exercisable within 60 days of the date of this filing, constituting approximately 9.70% of the issued and outstanding Class A Ordinary Shares of the Issuer (the “Shares”). The filing of this Schedule 13G shall not be construed as an admission that the Reporting Person, or any of its subsidiaries or affiliates, is or are the beneficial owners of the Shares for any other purpose than Section 13(d) and 13(g) of the Act, as amended.

Certification

Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to an investment company is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D. CUSIP No. G0411D107 Schedule 13G/A Page 4 of 4 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete, and correct. Date: May 30, 2024 /s/ Yi Kuei Chen Name: Yi Kuei Chen Title: Director

View Full Filing

View this SC 13G/A filing on SEC EDGAR